Paradise Genomics, founded in Northbrook, Illinois, is a biotechnology company dedicated to the discovery of gene expression bioprofiles for disease diagnosis. The company's core mission is to provide unmatched sensitivity and precision in genomic analysis, aiming to enhance diagnostic accuracy and reproducibility across various diseases. Paradise Genomics offers advanced gene signatures and has a strong focus on bioprofile discovery, particularly in whole blood or tissue samples.
The company has achieved significant milestones, including the identification of novel biomarkers for diseases such as fibromyalgia and colorectal cancer. Paradise Genomics collaborates with various partners to expand its research and discovery efforts. Its contributions have had a notable impact on the field of genomic diagnostics, providing valuable tools for early and accurate disease detection.
